March 20, 2006
Cervical Cancer Test Approved by FDA
A new system to detect precancerous cervical cancer cells has been approved by the FDA, increasing the odds that more women will be diagnosed early.
MediSpectra's LUMA Cervical Imaging System can detect pre-cancerous cells missed by colposcopy, a diagnostic tool used on women with an abnormal Pap smear. In 50 cases of pre-cancer detected during a clinical study of 193 women, nine were caught by the LUMA system after being missed by colposcopy, the FDA said in a news release. (Forbes.com)
